Edwards Lifesciences Inc. says it will appeal a Delaware judge’s decision not to bar the manufacture and sale of Medtronic Inc.’s CoreValve aortic valve replacement. Medtronic Inc. (NYSE:MDT) managed ...
Irvine-based heart valve maker Edwards Lifesciences Corp. is suing small rival CoreValve Inc. of Irvine for alleged patent infringement. Edwards, which is developing a heart valve that doesn’t require ...
Edwards Lifesciences and Medtronic have been battling each other for half a dozen years (at least) over a heart valve patent, and recent news suggests Germany's District Court of Mannheim will favor ...
Minneapolis-based Medtronic will appeal the Federal District Court of Delaware’s preliminary injuction granted to Irvine, Calif.-based Edwards Lifesciences. The Court issued the preliminary injunction ...
Nontransfemoral implantation, however, was not an independent predictor of mortality and likely reflected the higher risk of the patients treated this way. What's to Be Gleaned From UK TAVI? Speaking ...
Surgical aortic valve replacement (SAVR) devices are widely believed to be considerably more durable than transcatheter aortic valve replacement (TAVR) devices, but five-year data for Medtronic plc’s ...
CoreValve Inc., a French heart valve developer, is switching its headquarters from Paris to Irvine with an eye toward raising money to fund the development of its product. “There is no doubt that ...
Co announces it has filed a patent infringement lawsuit against CoreValve in the District Court of Dusseldorf, Germany. The suit seeks relief for alleged infringement of a patent for transcatheter ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below: Receive the the latest news, research, and presentations from major meetings ...
Medtronic wins US appeal to overturn $106.5 mln heart-valve patent verdict A U.S. appeals court on Friday overturned a jury's verdict that medical device maker Medtronic owes competitor Colibri $106.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results